{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Zaleplon  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Zaleplon. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Zaleplon  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "zaleplon",
    "trial_2_text": "Zaleplon  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Zaleplon Supplement: 60 participants will take Zaleplon 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Zaleplon. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Zaleplon  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.19203126430511475,
      "9": 0.17858169972896576,
      "17": 0.15547442436218262,
      "46": 0.10491843521595001,
      "68": 0.08982861042022705,
      "78": 0.08708122372627258,
      "49": 0.07756955176591873,
      "79": 0.07715867459774017,
      "77": 0.07513269037008286,
      "67": 0.06657615303993225,
      "173": 0.06428592652082443,
      "20": 0.06386175006628036,
      "177": 0.0637999027967453,
      "21": 0.0631900280714035,
      "37": 0.05953449755907059,
      "228": 0.05447370931506157,
      "64": 0.05180755630135536,
      "101": 0.04921596869826317,
      "123": 0.048411041498184204,
      "85": 0.0446680411696434,
      "66": 0.04336915165185928,
      "151": 0.04230981692671776,
      "200": 0.041983675211668015,
      "300": 0.04189906269311905,
      "104": 0.040343206375837326,
      "86": 0.03899182751774788,
      "126": 0.03762078657746315,
      "180": 0.03725055977702141,
      "132": 0.03711414709687233,
      "102": 0.03510972112417221,
      "114": 0.03349917382001877,
      "29": 0.03325403109192848,
      "234": 0.033152248710393906,
      "239": 0.031740956008434296,
      "14": 0.03150520473718643,
      "131": 0.0299221258610487,
      "76": 0.029817499220371246,
      "82": 0.029242459684610367,
      "199": 0.02908180095255375,
      "18": 0.02864057384431362,
      "36": 0.028516000136733055,
      "116": 0.027976589277386665,
      "189": 0.027276432141661644,
      "243": 0.02655434049665928,
      "188": 0.02479739300906658,
      "262": 0.024537596851587296,
      "139": 0.02446972019970417,
      "242": 0.024425119161605835,
      "5": 0.02425343170762062,
      "61": 0.02407234162092209,
      "28": 0.023565158247947693,
      "30": 0.023502279072999954,
      "96": 0.022716768085956573,
      "72": 0.022421004250645638,
      "136": 0.022375689819455147,
      "211": 0.0216353889554739,
      "204": 0.021011000499129295,
      "466": 0.020852424204349518,
      "350": 0.020286671817302704,
      "92": 0.01995941251516342,
      "193": 0.019826538860797882,
      "130": 0.01977921836078167,
      "69": 0.019769422709941864,
      "396": 0.01974431239068508,
      "38": 0.0195609237998724,
      "221": 0.01930677704513073,
      "456": 0.01885923743247986,
      "166": 0.01877107098698616,
      "138": 0.01861526630818844,
      "11": 0.018592122942209244,
      "345": 0.018300797790288925,
      "361": 0.018110940232872963,
      "122": 0.0180344395339489,
      "98": 0.017396321520209312,
      "286": 0.01691969484090805,
      "4": 0.0167331974953413,
      "441": 0.016671480610966682,
      "147": 0.01607021689414978,
      "422": 0.015879767015576363,
      "94": 0.015801267698407173,
      "339": 0.015475034713745117,
      "261": 0.015345991589128971,
      "75": 0.015155510976910591,
      "89": 0.015139677561819553,
      "2": 0.015111526474356651,
      "27": 0.014995938166975975,
      "191": 0.014995915815234184,
      "15": 0.014880177564918995,
      "249": 0.014855843968689442,
      "153": 0.014721011742949486,
      "269": 0.014701313339173794,
      "454": 0.014635413885116577,
      "142": 0.014500186778604984,
      "235": 0.014479954726994038,
      "195": 0.01435472909361124,
      "118": 0.014141453430056572,
      "355": 0.014015297405421734,
      "218": 0.013726959936320782,
      "179": 0.013658653013408184,
      "371": 0.013400021009147167
    },
    "trial_2_ae": {
      "87": 0.19203126430511475,
      "9": 0.17858169972896576,
      "17": 0.15547442436218262,
      "46": 0.10491843521595001,
      "68": 0.08982861042022705,
      "78": 0.08708122372627258,
      "49": 0.07756955176591873,
      "79": 0.07715867459774017,
      "77": 0.07513269037008286,
      "67": 0.06657615303993225,
      "173": 0.06428592652082443,
      "20": 0.06386175006628036,
      "177": 0.0637999027967453,
      "21": 0.0631900280714035,
      "37": 0.05953449755907059,
      "228": 0.05447370931506157,
      "64": 0.05180755630135536,
      "101": 0.04921596869826317,
      "123": 0.048411041498184204,
      "85": 0.0446680411696434,
      "66": 0.04336915165185928,
      "151": 0.04230981692671776,
      "200": 0.041983675211668015,
      "300": 0.04189906269311905,
      "104": 0.040343206375837326,
      "86": 0.03899182751774788,
      "126": 0.03762078657746315,
      "180": 0.03725055977702141,
      "132": 0.03711414709687233,
      "102": 0.03510972112417221,
      "114": 0.03349917382001877,
      "29": 0.03325403109192848,
      "234": 0.033152248710393906,
      "239": 0.031740956008434296,
      "14": 0.03150520473718643,
      "131": 0.0299221258610487,
      "76": 0.029817499220371246,
      "82": 0.029242459684610367,
      "199": 0.02908180095255375,
      "18": 0.02864057384431362,
      "36": 0.028516000136733055,
      "116": 0.027976589277386665,
      "189": 0.027276432141661644,
      "243": 0.02655434049665928,
      "188": 0.02479739300906658,
      "262": 0.024537596851587296,
      "139": 0.02446972019970417,
      "242": 0.024425119161605835,
      "5": 0.02425343170762062,
      "61": 0.02407234162092209,
      "28": 0.023565158247947693,
      "30": 0.023502279072999954,
      "96": 0.022716768085956573,
      "72": 0.022421004250645638,
      "136": 0.022375689819455147,
      "211": 0.0216353889554739,
      "204": 0.021011000499129295,
      "466": 0.020852424204349518,
      "350": 0.020286671817302704,
      "92": 0.01995941251516342,
      "193": 0.019826538860797882,
      "130": 0.01977921836078167,
      "69": 0.019769422709941864,
      "396": 0.01974431239068508,
      "38": 0.0195609237998724,
      "221": 0.01930677704513073,
      "456": 0.01885923743247986,
      "166": 0.01877107098698616,
      "138": 0.01861526630818844,
      "11": 0.018592122942209244,
      "345": 0.018300797790288925,
      "361": 0.018110940232872963,
      "122": 0.0180344395339489,
      "98": 0.017396321520209312,
      "286": 0.01691969484090805,
      "4": 0.0167331974953413,
      "441": 0.016671480610966682,
      "147": 0.01607021689414978,
      "422": 0.015879767015576363,
      "94": 0.015801267698407173,
      "339": 0.015475034713745117,
      "261": 0.015345991589128971,
      "75": 0.015155510976910591,
      "89": 0.015139677561819553,
      "2": 0.015111526474356651,
      "27": 0.014995938166975975,
      "191": 0.014995915815234184,
      "15": 0.014880177564918995,
      "249": 0.014855843968689442,
      "153": 0.014721011742949486,
      "269": 0.014701313339173794,
      "454": 0.014635413885116577,
      "142": 0.014500186778604984,
      "235": 0.014479954726994038,
      "195": 0.01435472909361124,
      "118": 0.014141453430056572,
      "355": 0.014015297405421734,
      "218": 0.013726959936320782,
      "179": 0.013658653013408184,
      "371": 0.013400021009147167
    }
  },
  "safety": {
    "trial_1_safety": 0.1963014453649521,
    "trial_2_safety": 0.1963014453649521
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4772072732448578
  }
}